Search by Drug Name or NDC

    NDC 70000-0129-01 Maximum Strength Mucus Relief DM 20; 400 mg/20mL; mg/20mL Details

    Maximum Strength Mucus Relief DM 20; 400 mg/20mL; mg/20mL

    Maximum Strength Mucus Relief DM is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by CARDINAL HEALTH. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 70000-0129
    Product ID 70000-0129_c732d183-f208-4fc8-b41f-d8856298cf51
    Associated GPIs 43997002520905
    GCN Sequence Number 023893
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 100-5 MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53497
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Maximum Strength Mucus Relief DM
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan hydrobromide and Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 20; 400
    Active Ingredient Units mg/20mL; mg/20mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name CARDINAL HEALTH
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 70000-0129-01 (70000012901)

    NDC Package Code 70000-0129-1
    Billing NDC 70000012901
    Package 180 mL in 1 BOTTLE (70000-0129-1)
    Marketing Start Date 2017-03-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.0185
    Pricing Unit ML
    Effective Date 2024-01-17
    NDC Description MUCUS RELIEF DM MAX LIQUID
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis